Literature DB >> 24252276

The effect of induction chemotherapy on tumor volume and organ-at-risk doses in patients with locally advanced oropharyngeal cancer.

Patricia Doornaert1, Max Dahele, Wilko F A R Verbakel, Omar Bohoudi, Ben J Slotman, Johannes A Langendijk.   

Abstract

BACKGROUND AND
PURPOSE: To retrospectively report changes in gross tumor volume (GTV) and organ-at-risk (OAR) doses after induction chemotherapy (IC) in oropharyngeal cancer using different contouring strategies.
MATERIALS AND METHODS: GTV and OARs were delineated on pre- and post-IC planning CT. Two post-IC GTV contours were made: (1) a 'consensus set' using published guidelines (GTVconsensus), and (2) 'visible set', delineating only visible post-IC GTV (GTVvisible). Pre-IC interactively optimized volumetric modulated arc therapy plans were generated. The pre-IC planning constraints served as the starting point for both post-IC plans. Results reflect pooled data from all 10 patients.
RESULTS: Mean reduction in volume post-IC was 24% and 47% for consensus and visible primary tumor and 57% and 60% for consensus and visible nodes. Compared to pre-IC plans, average mean OAR dose for post-IC GTVconsensus plans was significantly lower for CL parotid. For GTVvisible plans both parotids, upper/lower larynx, inferior pharyngeal constrictor and cricopharyngeal muscles were significantly lower. However reductions compared with post-IC GTVconsensus plans were modest (1.6/1.5/1.2/3.7/5.9/2.6Gy, respectively).
CONCLUSION: IC in patients with oropharyngeal carcinoma results in substantial reductions in GTVs. If post-IC GTVs are used, which is contrary to current consensus, statistically significant but relatively small OAR dose reductions are observed.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Induction chemotherapy; Organ-at-risk dose; Oropharynx cancer; Volumetric change

Mesh:

Year:  2013        PMID: 24252276     DOI: 10.1016/j.radonc.2013.07.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.

Authors:  N Patrik Brodin; Rafi Kabarriti; Mark Pankuch; Clyde B Schechter; Vinai Gondi; Shalom Kalnicki; Chandan Guha; Madhur K Garg; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-26       Impact factor: 7.038

2.  Future of Radiotherapy in Nasopharyngeal Carcinoma.

Authors:  Xue-Song Sun; Xiao-Yun Li; Qiu-Yan Chen; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Br J Radiol       Date:  2019-07-09       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.